Cargando…

Expression and methylation status of LAMA2 are associated with the invasiveness of nonfunctioning PitNET

The laminin subunit alpha 2 (LAMA2) gene encodes an alpha 2 chain, which constitutes one of the subunits of laminin 2 (merosin) and laminin 4 (s-merosin). In the current study, we investigated the relationship between LAMA2 promoter methylation status and the invasiveness of clinically nonfunctionin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ruo-Qiang, Lan, Yu-Long, Lou, Jia-Cheng, Lyu, Yi-Zhu, Hao, Yu-Chao, Su, Qian-Fei, Ma, Bin-Bin, Yuan, Zhong-Bo, Yu, Zhi-Kuan, Zhang, Hong-Qiang, Wang, Dong-Sheng, Zhu, Ting-Zhun, Ding, Yan, Zhang, Ning, Zhang, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351710/ https://www.ncbi.nlm.nih.gov/pubmed/30728939 http://dx.doi.org/10.1177/2042018818821296

Ejemplares similares

Two Pituitary Neuroendocrine Tumors (PitNETs) with Very High Proliferation and TP53 Mutation — High-Grade PitNET or PitNEC?
por: Saeger, Wolfgang, et al.
Publicado: (2021)

PitNETs and the gut microbiota: potential connections, future directions
por: Nie, Ding, et al.
Publicado: (2023)

Differentiation of silent corticotroph pituitary neuroendocrine tumors (PitNETs) from non-functioning PitNETs using kinetic analysis of dynamic MRI
por: Amano, Taishi, et al.
Publicado: (2023)

Expression and Clinical Significance of MDM2 in Non-Functioning PitNETs
por: Yao, Xiaohui, et al.
Publicado: (2023)

How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020
por: Trouillas, Jacqueline, et al.
Publicado: (2020)

Pituitary Apoplexy in Patients with Pituitary Neuroendocrine Tumors (PitNET)
por: Gheorghe, Ana-Maria, et al.
Publicado: (2023)

MON-288 TSH Deficiency in Patients on Somatostatin Analog for TSH-PitNET
por: Illouz, Frederic, et al.
Publicado: (2020)

Immunotherapy for Aggressive and Metastatic Pituitary Neuroendocrine Tumors (PitNETs): State-of-the Art
por: Feola, Tiziana, et al.
Publicado: (2022)

The Value of ER∝ in the Prognosis of GH- and PRL-Secreting PitNETs: Clinicopathological Correlations
por: Dumitriu-Stan, Roxana-Ioana, et al.
Publicado: (2023)

Single-cell sequencing identifies differentiation-related markers for molecular classification and recurrence prediction of PitNET
por: Zhang, Qilin, et al.
Publicado: (2023)

PMON104 Sellar Gangliocytoma-Pituitary Neuroendocrine Tumor (PitNET) Presenting As Acromegaly
por: Aurora, John, et al.
Publicado: (2022)

Touch imprint cytology is useful for the intraoperative pathological diagnosis of PitNETs’ surgical margins
por: Tanabe, Noriaki, et al.
Publicado: (2023)

FRI370 Hyperthyroidism And Acromegaly In A Patient With A Mature Plurihormonal PIT1 Lineage PitNET/Adenoma
por: Slack, Daniel, et al.
Publicado: (2023)

Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways
por: Serioli, Simona, et al.
Publicado: (2023)

Endoscopic Endonasal Transplanum–Transtuberculum Approach for Pituitary Adenomas/PitNET: 25 Years of Experience
por: Carretta, Alessandro, et al.
Publicado: (2023)

Lactotroph PitNET/adenoma associated to granulomatous hypophysitis in a patient with Crohn's disease: A case report
por: Pietrantoni, Alberto, et al.
Publicado: (2022)

P720R USP8 Mutation Is Associated with a Better Responsiveness to Pasireotide in ACTH-Secreting PitNETs
por: Treppiedi, Donatella, et al.
Publicado: (2022)

Granulomatous mastitis (GM) in a young woman with a previous history of prolactin-secreting PitNET and actual normal prolactinemia
por: Boldrini, Cristiana
Publicado: (2022)

Imaging of pituitary tumors: an update with the 5th WHO Classifications—part 1. Pituitary neuroendocrine tumor (PitNET)/pituitary adenoma
por: Tsukamoto, Taro, et al.
Publicado: (2023)

Fluorescence-guided detection of pituitary neuroendocrine tumor (PitNET) tissue during endoscopic transsphenoidal surgery available agents, their potential, and technical aspects
por: Vergeer, Rob A, et al.
Publicado: (2022)

THU099 The Challenging Management Of Silent Corticotroph PitNET—From Very Aggressive To Mild Course Of Disease During Long Follow Up
por: Bogusławska, Anna, et al.
Publicado: (2023)

Correction to: Imaging of pituitary tumors: an update with the 5th WHO Classifications—part 1. Pituitary neuroendocrine tumor (PitNET)/pituitary adenoma
por: Tsukamoto, Taro, et al.
Publicado: (2023)

Imaging of pituitary tumors: an update with the 5th WHO Classifications—part 2. Neoplasms other than PitNET and tumor-mimicking lesions
por: Tsukamoto, Taro, et al.
Publicado: (2023)

Correction to: Imaging of pituitary tumors: an update with the 5th WHO Classifications—part 2. Neoplasms other than PitNET and tumor-mimicking lesions
por: Tsukamoto, Taro, et al.
Publicado: (2023)

The Prognostic-Based Approach in Growth Hormone-Secreting Pituitary Neuroendocrine Tumors (PitNET): Tertiary Reference Center, Single Senior Surgeon, and Long-Term Follow-Up
por: Ferrés, Abel, et al.
Publicado: (2022)

Diagnosing Nonfunctional Pancreatic NETs in MEN1: The Evidence Base
por: van Treijen, Mark J C, et al.
Publicado: (2018)

Silencing NUDT21 Attenuates the Mesenchymal Identity of Glioblastoma Cells via the NF-κB Pathway
por: Lou, Jia-Cheng, et al.
Publicado: (2017)

Detection by fluorescence of pituitary neuroendocrine tumour (PitNET) tissue during endoscopic transsphenoidal surgery using bevacizumab-800CW (DEPARTURE trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-finding trial
por: Vergeer, Rob A, et al.
Publicado: (2021)

Dalai Lama
Publicado: (2020)

Dalaï-Lama
Publicado: (2020)

Lamas in loops
por: Lai, Eric C.
Publicado: (2003)

Correlation of LAMA3 with onset and prognosis of ovarian cancer
por: Tang, Lin, et al.
Publicado: (2019)

LAMA3 DNA methylation and transcriptome changes associated with chemotherapy resistance in ovarian cancer
por: Feng, Li-yuan, et al.
Publicado: (2021)

Retroperitoneal laparoscopic partial adrenalectomy (RLPA) for 20-40 mm nonfunctional adrenal tumors in the day surgery mode
por: Li, Xuwen, et al.
Publicado: (2022)

Dalai Lama at CERN
Publicado: (1983)

Visit of Dalay Lama
Publicado: (1983)

LABA/LAMA fixed-dose combinations versus LAMA monotherapy in the prevention of COPD exacerbations: a systematic review and meta-analysis
por: Chen, Ching-Yi, et al.
Publicado: (2020)

Impact and Clinical Predictors of Lymph Node Metastases in Nonfunctional Pancreatic Neuroendocrine Tumors
por: Jiang, Yu, et al.
Publicado: (2015)

Difference Analysis of the Composition of Iron (Hydr)Oxides and Dissolved Organic Matter in Pit Mud of Different Pit Ages in Luzhou Laojiao and Its Implications for the Ripening Process of Pit Mud
por: Jiao, Kairui, et al.
Publicado: (2023)

When is LABA/LAMA Better than LAMA in GOLD Group B or D Patients for Reducing Acute Exacerbations of COPD?
por: Shin, Hong-Joon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2l3g1iej42oi0s94nk0h0c5cfl